Jinhe Biotechnology CO., LTD. (SHE:002688)

SHE:002688 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	616.53	635.89	608.13	491.37	517.66	314.8
Trading Asset Securities	0.52	0.55	0.51	-	-	-
Cash & Short-Term Investments	617.05	636.45	608.64	491.37	517.66	314.8
Cash Growth	-6.61%	4.57%	23.87%	-5.08%	64.44%	-13.02%
Accounts Receivable	701.28	659.9	633.13	504.86	493.6	396.1
Other Receivables	26.15	13.01	67.15	12.12	11.22	17.95
Receivables	727.44	672.91	700.27	516.98	504.82	414.05
Inventory	666.18	635.28	670.55	675.91	577.2	447.26
Prepaid Expenses	-	-	0.19	0.25	0.31	0.9
Other Current Assets	90.23	76.06	59.93	62.01	49.97	63.13
Total Current Assets	2,101	2,021	2,040	1,747	1,650	1,240
Property, Plant & Equipment	2,281	2,322	2,052	1,623	1,209	1,045
Long-Term Investments	17.25	17.16	12.16	3.15	0.53	0.44
Goodwill	460.09	460.3	497.95	298.91	295.97	309.94
Other Intangible Assets	629.48	639.94	656.4	629.72	645.33	625.56
Long-Term Deferred Tax Assets	51.96	71.21	50.05	16.54	9.99	14.78
Long-Term Deferred Charges	94.39	92.12	102.43	88.32	75.35	69.45
Other Long-Term Assets	46.81	27.03	42.98	102.16	178.59	71.44
Total Assets	5,682	5,651	5,454	4,509	4,065	3,377
Accounts Payable	259.26	313.71	254.91	263.11	122.04	96.98
Accrued Expenses	20.1	25.16	99.62	47.4	36.65	38.76
Short-Term Debt	1,070	1,032	1,687	1,246	833.9	1,115
Current Portion of Long-Term Debt	390.59	301.19	82.31	44.79	85.24	83
Current Portion of Leases	-	-	7.13	6.56	1.95	-
Current Income Taxes Payable	33.32	25.89	1.1	1.23	5.21	1.64
Current Unearned Revenue	20.34	17.91	17.77	25.66	30.61	23.76
Other Current Liabilities	144.47	144.98	107.78	29.42	48.08	13.51
Total Current Liabilities	1,938	1,861	2,257	1,665	1,164	1,373
Long-Term Debt	867.55	965.79	497.49	296.22	87	135
Long-Term Leases	19.43	19.57	26.19	7.67	-	-
Long-Term Unearned Revenue	54.67	56.12	39.24	38.09	38.33	37.9
Long-Term Deferred Tax Liabilities	91.81	112.97	116.88	76.6	67.38	69.05
Other Long-Term Liabilities	152.62	135.07	-	-	11.64	11.91
Total Liabilities	3,124	3,151	2,937	2,083	1,368	1,627
Common Stock	771.69	771.69	780.42	780.42	780.42	635.29
Additional Paid-In Capital	884.46	879.51	896.48	888.96	1,079	421.94
Retained Earnings	766.63	715.52	690.64	679.56	603.94	573.48
Treasury Stock	-138.86	-138.86	-131.89	-131.89	-	-
Comprehensive Income & Other	19.13	18.75	11.14	4.61	-25.2	-15.82
Total Common Equity	2,303	2,247	2,247	2,222	2,438	1,615
Minority Interest	254.99	253.25	269.89	203.63	258.28	135.06
Shareholders' Equity	2,558	2,500	2,517	2,425	2,696	1,750
Total Liabilities & Equity	5,682	5,651	5,454	4,509	4,065	3,377
Total Debt	2,347	2,319	2,300	1,602	1,008	1,333
Net Cash (Debt)	-1,730	-1,682	-1,691	-1,110	-490.44	-1,019
Net Cash Per Share	-2.24	-2.17	-2.17	-1.42	-0.70	-1.56
Filing Date Shares Outstanding	772.15	761.43	753.75	753.75	780.42	635.29
Total Common Shares Outstanding	772.15	761.43	753.75	753.75	780.42	635.29
Working Capital	162.99	159.49	-217.74	81.88	486.27	-132.91
Book Value Per Share	2.98	2.95	2.98	2.95	3.12	2.54
Tangible Book Value	1,213	1,146	1,092	1,293	1,497	679.38
Tangible Book Value Per Share	1.57	1.51	1.45	1.72	1.92	1.07
Buildings	-	-	918.97	806.47	671.81	645.33
Machinery	-	-	1,586	1,515	1,145	1,109
Construction In Progress	-	-	645.56	300.79	289.91	123.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.